Budget Impact Analysis: Methods & Data Patsi Sinnott, PT, PhD February 1, 2012.

Slides:



Advertisements
Similar presentations
Health Economics and ONS
Advertisements

Study Objectives and Questions for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Cost-Effectiveness Using Decision-Analytic Models
All Payer Claims Database APCD Databases created by state mandate, that includes data derived from medical, eligibility, provider, pharmacy and /or dental.
Economic Analysis and Management Todd Wagner, PhD.
Recommendations for Conducting Cost Effectiveness: Elements of the Reference Case Ciaran S. Phibbs, Ph.D. February 25, 2009.
Quality improvement for asthma care: The asthma care return-on-investment calculator Ginger Smith Carls, M.A., Thomson Healthcare (Medstat) State Healthcare.
Journal Club Alcohol and Health: Current Evidence March-April 2006.
Documentation for Acute Care
Productivity Prepared by Dr. Manal Moussa. Productivity Prepared by Dr. Manal Moussa.
Budget Impact Analysis and Return on Investment Usa Chaikledkaew, Ph.D.
Cost-effectiveness of converting non- sedating antihistamines from prescription to over-the-counter status Michael B. Nichol, Ph.D. Patrick Sullivan, Ph.D.
Assessing Health and Economic Outcomes William C. Black, M.D. Director ACRIN Outcomes & Economics Core Laboratory Dartmouth-Hitchcock Medical Center.
Standard 5: Patient Identification and Procedure Matching Nicola Dunbar, Accrediting Agencies Surveyor Workshop, 10 July 2012.
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
Budget Impact Analysis A worked example
Disease Management: High Risk Groups Principles in Practice Copyright © – Academy of Managed Care Pharmacy (AMCP)Slide 1.
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
Economics of Implementation: Moving beyond Traditional CEA Mark Smith Paul Barnett VA Health Economics Resource Center.
Pharmacy Data Mark W. Smith, PhD April Topics Overview of Data Sources Access & File Names Highlights of Contents Guidance for Use Non-VA Pharmacy.
Estimating Cost at Each Stage of Care Mark Smith, PhD Paul Barnett, PhD Ciaran Phibbs, PhD HERC Cyberseminar February 28, 2007.
PHAR 310: Pharmacoeconomics
Consumer-Driven Health Plans: Early Evidence about Utilization, Spending and Cost Stephen T Parente Roger Feldman Jon B Christianson October, 2003.
EVIDENCE BASED MEDICINE Health economics Ross Lawrenson.
Inpatient, Outpatient, and Pharmacy Costs from the Decision Support System (DSS) Jean Yoon October 3, 2012.
ACCOUNTING FOR HEALTHCARE Pertemuan 8-12 Matakuliah: A1042/Accounting Software Package for Services Tahun: 2010.
VA Health Care Data at the Austin Automation Center Paul G. Barnett, PhD April 4, 2003.
Budget Impact Analysis: Methods & Data Patsi Sinnott, PT, PhD November 28, 2012.
Cost-Effectiveness of Palliative Team Care For Patients Nearing End-Of-Life Society for Medical Decision Making 36 st Annual Meeting – Miami, Florida October.
Economics of Implementation: Moving beyond Traditional CEA Mark Smith Paul Barnett VA Health Economics Resource Center.
Mohammad Aljawadi PharmD, PhD Clinical Pharmacy Department King Saud University PHCL 431 Sep, 2015.
Budget Impact Analysis: Methods & Data Mark W. Smith, PhD May 12, 2010 VA HSR&D Health Economics Resource Center 795 Willow Road (152 MPD), Menlo Park,
Cost-Effectiveness and Cost-Benefit Analysis N287E Spring 2006 Joanne Spetz 31 May 2006.
Enhancing Equitable and Effective PTSD Disability Assessment (E3-PTSD) Ted Speroff, PhD, PI; TVHCS Patricia Sinnott, PT, PhD, MPH, co-PI;HERC.
“Reaching across Arizona to provide comprehensive quality health care for those in need” AHCCCS/ADHS Report Summary & Recommendations.
How Can Cost Effectiveness Analysis Be Made More Relevant to U.S. Health Care? Paul G. Barnett, PhD February 29, 2012.
Inpatient and Outpatient Costs from DSS Jean Yoon Paul Barnett March 25, 2009.
Fee Basis & NPPD Data Mark W. Smith, Ph.D. August 3, 2005 Health Economics Teleconference Seminar access code
An Overview of VA Pharmacy Data Mark W. Smith February, 2010.
Mark W. Smith July 28, 2010 Fee Basis Data. Overview of Fee Basis Program Pays for care at non-VA facilities when –it is the only source available, or.
Articulating the Value of Consumer Engagement 2 – 3:30 pm ET July 25, 2013.
VA Decision Support System (DSS) Paul G. Barnett PhD Wei Yu, PhD Samuel King, MS Ciaran Phibbs, PhD July 20, 2005.
Budget Impact Analysis: Methods & Data Mark W. Smith, PhD VA HSR&D Health Economics Resource Center 795 Willow Road (152 MPD), Menlo Park, CA
© 2014 American Orthotic & Prosthetic Association All rights reserved.
VA Economic Data Sets I: Utilization Paul G. Barnett, PhD June 15, 2005 VA Health Economics Course.
VA Economic Data Sets: CDR, MPCR, Person-level cost Todd Wagner.
Inpatient and Outpatient Costs from DSS Jean Yoon Paul Barnett February 10, 2010.
Advances in VA Utilization and Cost Data VA HSR&D National Meeting February 16, 2005 Mark W. Smith Paul Barnett Todd Wagner.
Estimating the Cost of Health Care: VA Costs Paul Barnett May 16, 2007.
Introduction to decision analysis modeling Alice Zwerling, Postdoctoral fellow, JHSPH McGill TB Research Methods Course July 7, 2015.
Show Me the Money- Delivering Ethical and Reimbursable Services within Healthcare Payer Sources Amber Heape, MCD, CCC-SLP, CDP Clinical Specialist- PruittHealth.
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
1 Edward Broughton, PhD., MPH Director of Research and Evaluation, USAID Health Care Improvement Project, University Research Co., LLC
Economics of Complementary and Integrative Medicine: Where Do We Go From Here? Patricia M. Herman, ND, PhD, RAND Corporation IM4US Boston August 8, 2014.
Inpatient, Outpatient, and Pharmacy Costs from DSS Jean Yoon October 12, 2011.
Geographic Variation in Healthcare and Promotion of High-Value Care Margaret E. O’Kane November 10, 2010.
ACTIVITY-BASED COSTING (ABC)
IE 485 «Decision Making in Health Care»
Pharmacy & Therapeutics Committee
Home Based Palliative Care
Cost effectiveness Analysis: Valuing Health; Valuing Research!
HEALTH ECONOMICS BASICS
Strategies to incorporate pharmacoeconomics into pharmacotherapy
Pharmacy & Therapeutics Committee
For Patients: Frequently Asked Questions
For Patients: Frequently Asked Questions
Pharmacy & Therapeutics Committee
DIFFERENT MEANINGS OF COST
Presentation Developed for the Academy of Managed Care Pharmacy
Pharmacy & Therapeutics Committee
Presentation transcript:

Budget Impact Analysis: Methods & Data Patsi Sinnott, PT, PhD February 1, 2012

Budget Impact Analysis: Overview Analysis of expenditures for a program over a short period (often 1-3 years), including the effect of any offsetting savings. –Evaluates a scenario rather than a single action –Includes comparison to the status quo –Includes sensitivity analysis

Budget Impact Analysis: Overview To estimate feasibility/affordability For budgeting/forecasting What are your partners asking? –How much will this cost –Now – later – much later? 3

Budget Impact Analysis: Framework Estimating –The cost of the intervention –Changes in staffing, schedules and use of technology –Changes in pt. access/throughput/demand –Potential Savings –Cost to operate 4

Budget Impact Analysis: Perspective BIA takes the buyer/provider/payer’s perspective.

Budget Impact Analysis: Horizon BIA uses a short horizon – usually a few years at most. Long-term modeling is unnecessary. Costs are not discounted Savings in far future cannot offset initial/start-up or investment costs.

Budget Impact Analysis: Utility BIA does not measure utility. No need to survey patients. No calculation of QALYs.

Conceptual Diagram Source: Mauskopf et al. (2007)

Diagram redux Current Environment Key FactorsBudget impact analysis ImpactsNew Environment Total Population Incidence and prevalence New Total Population Sick population % diagnosed and % treated Diagnosis and treatment New Sick population Target Population Current treatment regimen New therapy or procedure New Target Population Resource Utilization Unit costUnit costs New Resource Utilization Cost of IllnessNew Cost of Illness 9

Reference Scenario/ Current Environment Population 1. How many patients are getting care? 2. Who gets care? –essential: clinical characteristics –advanced: enrollment priority, VERA category –how many need VA-funded transportation? 3. What is the size of the target population?

Reference Scenario/ Current Environment What treatment(s) are the current population getting? What other healthcare resources is the current population getting? 11

Reference Scenario – The Intervention(s) What is “the intervention”? Where is it provided? How often is it provided? Who provides the care? What do the providers do when they are “providing the care”? What resources, technologies, etc are used?

Comparison Scenario Relative to reference scenario, how will these change? –Demand for care (number of patients seeking care) –will new patients be drawn into the system? –will new patients become eligible for contract care, home care, anything else outside VA? –Is the incidence or prevalence changing –Future need for care, within BIA horizon –Copayments collected, VERA payments received

Comparison Scenario Relative to reference scenario, how will these change? –Staff mix & consequent costs –mix of MDs, NPs, RNs –how will staff changes affect costs? –Space and other overhead costs –clinical space requirements –will new space be rented, purchased, or built? –Technology purchase/repair costs

Modeling Static models –Simple calculation of cost impact from changing one or two factors, holding everything else constant –May be sufficient if the alternative and reference scenarios are quite similar and probabilities are well known Dynamic models –Decision model, such as a Markov model: captures uncertainty, such as over impact on enrollment or probability of clinical outcomes –Discrete event analysis

BIA in Implementation Research Include cost of implementation program Consider: –What implementation costs should be included? –Will implementation costs change/disappear over time? –Can implementation be made more efficient? –How generalizable is the local implementation approach? You may need to develop alternative scenarios for other locations.

Budget Impact Analysis: Framework Estimating –The cost of the intervention –Changes in staffing, schedules and use of technology –Changes in pt. access/throughput/demand –Potential Savings –Cost to operate 17

Why Both CEA and BIA? CEA addresses societal perspective –implementation won’t occur without proof that “best practice” is cost-effective BIA addresses provider perspective –influential in implementation decisions

Costing in the BIA Using the perspective of VA: –VA’s costs: yes –Patient’s costs: no (earnings, transportation, time) –Society’s costs:no (other payers, employer, caregivers) Estimate the amount of change in units of care Estimate the amount of change in cost per unit of care

Cost Data Sources: Encounters Decision Support System (DSS) National Data Extracts (NDEs) –Inpatient files –discharge (one record per stay) –bedsection (one record per bedsection segment of the stay) –Outpatient files –Encounters: one record per person-clinic-day –Pharmacy: one record per prescription

Cost Data Sources: Encounters HERC Average Cost data –Inpatient files –discharge: can be linked to PTF discharge files –med/surg discharges and non-med/surg discharges: can be linked to PTF bedsection files –Outpatient files –encounters: can be linked to OPC –pharmacy: none except when delivered in clinic (use DSS or PBM pharmacy data)

Cost Data Sources: Encounters HERC Average Cost data vs. DSS –Uses Medicare relative value units (RVUs) not DSS RVUs –Less granularity = more similarity in costs across encounters For comparison to DSS costs, see HERC publications: –Go to HERC intranet web site –Choose Publications –Choose Technical Reports

Cost Data Sources: Staff Average hourly staff cost for 70+ occupation categories can be figured using either of two sources: –DSS ALBCC –Financial Management System OR Use HERC technical report #12 supplement, which has figured them for FY2001-FY2008.

Cost Data Sources: Supplies, Machines National Prosthetics Patient Database (NPPD) –records purchase price of all items ordered through the VISTA Prosthetics and Sensory Aids package –includes nearly all medical items for internal and external use, not just prosthetics or sensory aids (glasses, hearing aids) –stored and handled by NPPD data manager at Hines VAMC Your local A&MMS purchasing officer

Cost Data Sources: Indirects PG Barnett, M Berger. Indirect Costs of Specialized VA Mental Health Treatment. HERC Technical Report #6. (on HERC web site) Rosenheck R, Neale M, Frisman L. Issues in estimating the cost of innovative mental health programs. Psychiatric Quarterly 1995;66(1):9-31

Sensitivity Analyses Purpose: to test the robustness of your results Method: change assumptions in your model and see how the final outcome changes Univariate: change one at a time –Easy, but possibly misleading –Not considered state-of-the-art Multivariate: change multiple assumptions at once –Probably will require software and/or a formal model –High credibility –Allows useful graphing

BIA requires six items: 1. Size and characteristics of patient population 2. Usual care: current mix of care offered to current population 3. Cost of usual care 4. New care: mix of care under the new intervention 5. Cost of new care/intervention 6. Use and cost of other health care services related to the intervention and the condition under study Source: Mauskopf et al. (2007) Summary

Resources HERC web site ( –Guidebooks[most on intranet site only] –Technical reports[most on intranet site only] –FAQ responses –Slides from training courses (cyber-seminars) VIREC web site ( –Research user guides (RUGs) on DSS, PTF, OPC –Technical reports (pharmacy)

Many articles on decision modeling and discrete event analysis appear in these journals: – Medical Decision Making – Health Economics – Value in Health Resources

ISPOR recommendations on BIA: Mauskopf J, Sullivan SD, Annemans L, et al. Principles of Good Practice for Budget Impact Analysis: Report of the ISPOR Task Force on Good Research Practices – Budget Impact Analysis. Value in Health 2007;10(5): VA-funded literature review on budget impact analysis: Luck J, Parkerton P, Hagigi F. What is the business case for improving care for patients with complex conditions? Journal of General Internal Medicine 2007;22(Suppl 3): Resources

Next HERC Course “How can Cost Effectiveness Analysis be Made More Relevant to US Health Care?” Paul Barnett, PhD February 29,